|4Oct 15, 8:20 PM ET

CANCER GENETICS, INC 4

4 · CANCER GENETICS, INC · Filed Oct 15, 2013

Insider Transaction Report

Form 4
Period: 2013-10-10
El Naggar Jane Houldsworth
VP of Research and Development
Transactions
  • Award

    Stock Option (right to buy)

    2013-10-10+10,00010,000 total
    Exercise: $15.39Exp: 2023-10-09Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]20% of the shares underlying the option vest on the one year anniversary of the date on which the option was granted, and the remaining shares vest in 48 equal monthly installments commencing one month following the one year anniversary of the grant date.

Documents

2 files
  • 4
    doc1.xmlPrimary

    FORM 4

  • EX-24.1

    POWER OF ATTORNEY